Friday 23rd June, 2017
Translate Language:::
Share

'Huge advance' in fighting world's biggest killer

'Huge advance' in fighting world's biggest killer

An innovative new drug can prevent heart at­tacks and strokes by cutting bad cholesterol to un­precedented levels, say doc­tors.
The results of the large in­ternational trial on 27,000 pa­tients means the drug could soon be used by millions.
The British Heart Founda­tion said the findings were a significant advance in fight­ing the biggest killer in the world.
Around 15 million people die each year from heart at­tacks or stroke.
Bad cholesterol is the vil­lain in the heart world - it leads to blood vessels furring up, becoming easy to block which fatally starves the heart or brain of oxygen.
It is why millions of peo­ple take drugs called statins to reduce the amount of bad cholesterol.
The new drug - evolocum­ab - changes the way the liv­er works to also cut bad cho­lesterol.
“It is much more effective than statins,” said Prof Peter Sever, from Imperial College London.
He organised the bit of the trial taking place in the UK with funding from the drug company Amgen.
Prof Sever told the BBC News website: “The end re­sult was cholesterol levels came down and down and down and we’ve seen cho­lesterol levels lower than we have ever seen before in the practice of medicine.”

SHARE ON: